Lynn Schuchter of the Perelman School of Medicine discusses the results of a clinical trial that introduces a “triple threat” combination that could be effective in treating melanoma.
Lynn Schuchter of the Perelman School of Medicine discusses the results of a clinical trial that introduces a “triple threat” combination that could be effective in treating melanoma.